Log in to save to my catalogue

CAR T cells for the long run in aggressive B-cell lymphoma

CAR T cells for the long run in aggressive B-cell lymphoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2572530151

CAR T cells for the long run in aggressive B-cell lymphoma

About this item

Full title

CAR T cells for the long run in aggressive B-cell lymphoma

Author / Creator

Publisher

London: Elsevier Ltd

Journal title

The lancet oncology, 2021-10, Vol.22 (10), p.1347-1348

Language

English

Formats

Publication information

Publisher

London: Elsevier Ltd

More information

Scope and Contents

Contents

Since first being reported in 2010,1 CD19-directed chimeric antigen receptor (CAR) T cells have led a revolution in the treatment of B-cell non-Hodgkin lymphomas. [...]the follow-up period was substantially extended, with a median of 40·3 months (IQR 37·8–43·8), and so the Article shows truly long-term patient outcomes. The findings reported by Sch...

Alternative Titles

Full title

CAR T cells for the long run in aggressive B-cell lymphoma

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2572530151

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2572530151

Other Identifiers

ISSN

1470-2045,1474-5488

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(21)00412-5

How to access this item